Kamada (KMDA) Cost of Revenue (2012 - 2026)
Kamada (KMDA) recorded Cost of Revenue of $32.45 million in the quarter ended Jun 30, 2026, up 25.7% from $25.83 million a year earlier and up 24.2% from the prior quarter.
Kamada (KMDA) Cost of Revenue (2012 - 2026) Analysis & Trends
On a TTM basis, Kamada's Cost of Revenue came in at $113.54 million as of Jun 30, 2026, up 18.8% year-over-year; for the year ended Dec 31, 2025, it came in at $104.05 million, up 14.4% from the prior year.
- Annual Cost of Revenue has increased for four straight years, with a five-year compound annual growth rate of 4.0% (years ended Dec 2020 to Dec 2025).
- Across earlier years, Cost of Revenue came in at $90.99 million in the year ended Dec 31, 2024 (+4.5%), $87.03 million in the year ended Dec 31, 2023 (+5.3%), $82.64 million in the year ended Dec 31, 2022 (+12.7%) and $73.31 million in the year ended Dec 31, 2021 (-14.4%).
- The figure for the quarter ended Jun 30, 2026 is the highest quarterly Cost of Revenue since the quarter ended Sep 30, 2017.
- On a year-over-year basis, Cost of Revenue has increased for six consecutive quarters, with growth averaging 12.7% over the last eight quarters.
- Peak year-over-year performance for Cost of Revenue in the last five years was growth of 40.7% in the quarter ended Jun 30, 2023, against a decline of 27.0% in the quarter ended Dec 31, 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $26.12 million (quarter ended Mar 31, 2026), $27.71 million (quarter ended Dec 31, 2025) and $27.25 million (quarter ended Sep 30, 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.27 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 8.05 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.29 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 4.40 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.71 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.52 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.81 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.58 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.09 Bn |
| 10 | Kamada | 479.37 Mn | 188.43 Mn | 22.47 Mn | 32.45 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 32.45 Mn |
| Mar 31, 2026 | 26.12 Mn |
| Dec 31, 2025 | 27.71 Mn |
| Sep 30, 2025 | 27.25 Mn |
| Jun 30, 2025 | 25.83 Mn |
| Mar 31, 2025 | 23.27 Mn |
| Dec 31, 2024 | 21.97 Mn |
| Sep 30, 2024 | 24.51 Mn |
| Jun 30, 2024 | 23.52 Mn |
| Mar 31, 2024 | 20.99 Mn |
| Dec 31, 2023 | 22.02 Mn |
| Sep 30, 2023 | 23.13 Mn |
| Jun 30, 2023 | 23.01 Mn |
| Mar 31, 2023 | 18.87 Mn |
| Dec 31, 2022 | 30.15 Mn |
| Sep 30, 2022 | 19.35 Mn |
| Jun 30, 2022 | 16.35 Mn |
| Mar 31, 2022 | 16.79 Mn |
| Dec 31, 2021 | 24.87 Mn |
| Sep 30, 2021 | 17.30 Mn |
Kamada Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=KMDA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "KMDA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=KMDA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();